English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis

MPS-Authors
/persons/resource/persons82141

Schmidt,  Nicole
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81899

Gonzalez,  Erik
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82197

Visekruna,  Alexander
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82058

Mollenkopf,  Hans J.
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81969

Kaufmann,  Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82175

Steinhoff,  Ulrich
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81956

Joeris,  Thorsten
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Schmidt, N., Gonzalez, E., Visekruna, A., Kühl, A. A., Loddenkemper, C., Mollenkopf, H. J., et al. (2010). Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut, 59(7), 896-906.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-BFD2-6
Abstract
There is no abstract available